Corcept Therapeutics Inc (CORT)
36.42
-0.14%
Corcept Therapeutics Inc (CORT) is currently trading at $36.42. This represents a loss of 0.14% from the previous session. With a market capitalization of $3.81B, CORT is a key component of the Health Care sector. Investors looking to trade CORT should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade CORT commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Corcept Therapeutics Inc (CORT) shows a bearish trend. Analysts are watching the 38.22 level closely.
Fundamentals
Mkt Cap3.81B
P/E Ratio0.0000
Volume2,359,666
60-Day Technical Chart
Advanced Charting
Need more indicators for CORT? Use the world's #1 platform.
Open CORT on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $36
| Metric |
CORT -0.14% |
SMCI +7.53% |
IONQ +6.29% |
WOW +12.97% |
|---|---|---|---|---|
| Price | $36.42 | $33.63 | $33.58 | $35.63 |
| Mkt Cap | $3.81B | $20.20B | $12.11B | $43.53B |
| - | View → | View → | View → |
Latest Headlines
CORT Stock Slips After-Hours On Weak Q4 Print: Retail Is Watching April FDA Meeting For Relacorilant As Next Catalyst
Stocktwits • Feb 25, 2026
Corcept Therapeutics (CORT) Price Target Lowered by Analyst | CO
GuruFocus • Feb 25, 2026
Corcept Therapeutics: The Bad News Is Priced In, The Ovarian Cancer Upside Is Not (CORT)
Seeking Alpha • Feb 20, 2026
INVESTOR ALERT: Corcept Therapeutics Incorporated Investors
GlobeNewswire • Feb 21, 2026
Corcept Therapeutics Stock: Why FDA Drama Is Not the Whole Story
AD HOC NEWS • Feb 24, 2026
● Gemini Agentic AI Analyst Insight for CORT
Market Education
- Money Cycle - Read once so simple Jun 6, 2021
- Are Cruise Stocks Finally Back on Course After a Rocky Five Years? Sep 27, 2025
- Long Short Strategy to Manage Risk May 31, 2024
External Research